• 主题
高级搜索  >
历史搜索 清空历史
首页> 外国专利> Therapeutic agent for irritative bladder symptoms associated with benign prostatic hyperplasia, use of tricyclic compound or its pharmaceutically acceptable salt, and method for treating irritative bladder symptoms associated with benign prostatic hyperplasia

Therapeutic agent for irritative bladder symptoms associated with benign prostatic hyperplasia, use of tricyclic compound or its pharmaceutically acceptable salt, and method for treating irritative bladder symptoms associated with benign prostatic hyperplasia

机译：用于治疗与前列腺增生相关的膀胱刺激性症状的治疗剂，三环化合物或其药学上可接受的盐的用途以及用于治疗与前列腺增生相关的膀胱刺激性症状的方法

页面导航
  • 摘要
  • 著录项
  • 相似文献

摘要

"THERAPEUTIC AGENT FOR IRRITATIVE SYMPTOMS OF THE BLADDER ASSOCIATED WITH BENIGNA PROSTATIC HYPERPLASIA, USE OF THE TRICYCLIC COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT, AND METHOD TO TREAT THE IRRITATIVE BRITISH SYMPTOMS WITH THE BENEFICIAL PROSTATIC SYMPTOMS. Remedies for bladder stimulation in combination with prostatauxe containing as active ingredient tricyclic compounds represented by the following general formula (I) or pharmacologically acceptable salts thereof: (1) wherein R4 is hydrogen, optionally substituted lower alkyl, etc .; X ^ 1 ^ -X ^ 2 ^ -X ^ 3 ^ represents CR ^ 5 ^ = CR ^ 6 ^ -CR ^ 7 ^ = CR ^ 8 ^, CR ^ 5 ^ = CR ^ 6 ^ -S, etc .; Y represents -CH ~ 2-S-, SOCH-2 ~, etc .; and represents hydrogen, etc.
机译：“治疗与贝尼加纳前列腺增生症相关的膀胱的过敏性症状的治疗剂，使用三环类化合物或药学可接受的盐，以及在刺激性前列腺癌与前列腺活性联合症状的治疗性前列腺癌中联合治疗的方法。由以下通式（I）表示的成分三环化合物或其药理学上可接受的盐：（1）其中R4为氢，任选取代的低级烷基等; X ^ 1 ^ -X ^ 2 ^ -X ^ 3 ^代表CR ^ 5 ^ = CR ^ 6 ^ -CR ^ 7 ^ = CR ^ 8 ^，CR ^ 5 ^ = CR ^ 6 ^ -S等; Y表示-CH〜2-S-，SOCH-2〜等。;代表氢等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号